Skip to main content
SpringerLink
Log in

Guidelines for submitting adverse event reports for publication are necessary to ensure published reports have value

  • Practical Issues and Updates
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

References

  1. Kelly WN, Arellano FM, Barnes J, et al. Guidelines for submitting adverse event reports for publication. Drug Saf 2007; 30(5): 367–73

    Article  PubMed  Google Scholar 

  2. Kelly WN. The quality of published adverse drug event reports. Ann Pharmacother 2003; 37(12): 1774–8

    Article  PubMed  Google Scholar 

  3. Hill AB. The environment and disease: association or causation? Proc R Soc Med 1965; 58: 295–300

    PubMed  CAS  Google Scholar 

  4. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239–45

    Article  PubMed  CAS  Google Scholar 

  5. Edwards IR, Lindquist M, Wiholm BE, et al. Quality criteria for early signals of possible adverse drug reactions. Lancet 1990; 336(8078): 156–8

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Guidelines for submitting adverse event reports for publication are necessary to ensure published reports have value. Drugs Ther. Perspect 24, 24–26 (2008). https://doi.org/10.2165/00042310-200824020-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200824020-00009

Keywords

Search

Navigation